You can read Premium News stories in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
9 September 2019
Perrigo is acquiring the US OTC rights to Prevacid 24HR (lansoprazole) from GlaxoSmithKline for an undisclosed sum. The company said the deal advanced its "Consumer Self-Care growth strategy".
20 August 2019
GlaxoSmithKline (GSK) Consumer Healthcare is seeking to extend its range of OTC nicotine-replacement therapy (NRT) products in the US with a nicotine oral spray.
1 August 2019
GlaxoSmithKline (GSK) and Pfizer have now completed the deal to combine their consumer healthcare businesses into a world-leading joint venture.
26 July 2019
Worldwide sales at GlaxoSmithKline's (GSK's) Consumer Healthcare business increased by 4% at constant exchange rates in the second quarter of 2019. The company said growth had been driven primarily by the performance of its powerbrands, including Sensodyne with sales growth of 7%.
15 July 2019
The European Commission has given the go-ahead to GlaxoSmithKline's (GSK's) proposed consumer healthcare joint venture with Pfizer, provided the ThermaCare pain-management brand is divested.
25 June 2019
GlaxoSmithKline (GSK) appears to have offered concessions to the European Commission as it seeks approval for its proposed consumer healthcare joint venture with Pfizer. Meanwhile, media reports suggest GSK has started a sale process for three portfolios of consumer healthcare products with a combin...
10 June 2019
Stada Arzneimittel is acquiring a portfolio of OTC brands, including Oilatum and Savlon Antiseptic Cream, from GlaxoSmithKline Consumer Healthcare for an undisclosed sum.
13 May 2019
Worldwide sales at GlaxoSmithKline's (GSK's) Consumer Healthcare business increased by 1% at constant exchange rates in the first quarter of 2019. The company's shareholders have just approved the proposed consumer healthcare joint venture with Pfizer.
8 May 2019
Crown Laboratories has boosted its skincare offering in North America by acquiring the Keri brand from GlaxoSmithKline (GSK) for an undisclosed sum.
5 March 2019
The planned joint venture between GlaxoSmithKline (GSK) and Pfizer is the winner of the 2019 OTCToolbox Consumer Healthcare Industry (CHi) Award for Transaction of the Year.